Koers Epsilon Healthcare Limited Other OTC
Aandelen
HDRPF
AU0000137598
Farmaceutische producten
Omzet 2021 | 5,5 mln. 3,63 mln. 3,36 mln. | Omzet 2022 | 7,11 mln. 4,7 mln. 4,34 mln. | Marktkapitalisatie | 7,51 mln. 4,96 mln. 4,59 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -5,94 mln. -5,5 mln. | Nettowinst (verlies) 2022 | -13 mln. -8,59 mln. -7,94 mln. | EV/omzet 2021 | 3,26 x |
Nettoschuld 2021 | 2,1 mln. 1,39 mln. 1,28 mln. | Nettoschuld 2022 | 2,34 mln. 1,54 mln. 1,43 mln. | EV/omzet 2022 | 1,38 x |
K/w-verhouding 2021 |
-1,48
x | K/w-verhouding 2022 |
-0,38
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 60,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 21/11 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 23-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 29-08-16 |
Stuart Cameron
BRD | Director/Board Member | - | 27-10-22 |
Xiao Cui
CHM | Chairman | - | 28-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,69% | 723 mld. | |
+34,28% | 595 mld. | |
-4,49% | 369 mld. | |
+20,24% | 332 mld. | |
+2,12% | 282 mld. | |
+17,02% | 244 mld. | |
+9,31% | 208 mld. | |
-5,07% | 205 mld. | |
-0,35% | 168 mld. |